Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases
Abstract Immune checkpoint inhibitors (ICIs) have resulted in improved outcomes in non-small cell lung cancer (NSCLC) patients. However, data demonstrating the efficacy of ICIs in NSCLC brain metastases (NSCLCBM) is limited. We analyzed overall survival (OS) in patients with NSCLCBM treated with ICI...
Guardado en:
Autores principales: | Adam Lauko, Rupesh Kotecha, Addison Barnett, Hong Li, Vineeth Tatineni, Assad Ali, Pradnya Patil, Alireza M. Mohammadi, Samuel T. Chao, Erin S. Murphy, Lilyana Angelov, John H. Suh, Gene H. Barnett, Nathan A. Pennell, Manmeet S. Ahluwalia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e1027f0afb7f466d803752a48a7d5614 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases
por: Adam Lauko, et al.
Publicado: (2021) -
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases
por: Adam Lauko, et al.
Publicado: (2021) -
Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States
por: Raees Tonse, et al.
Publicado: (2021) -
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases
por: Sanjay M. Prakadan, et al.
Publicado: (2021) -
Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance
por: Raees Tonse, et al.
Publicado: (2021)